BioVie (BIVI) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

BIVI BioVie

Watchlist

1.830
+0.060+3.39%

Close Feb 14 16:00 ET

1.850
+0.020+1.09%

Post 18:26 ET

33.77MMarket Cap-0.56P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Is BioVie (NASDAQ:BIVI) In A Good Position To Invest In Growth?
Yahoo FinanceFeb 13 06:31 ET
BioVie | 10-Q: Q2 2025 Earnings Report
SECFeb 11 17:06 ET · Announcements
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
BenzingaJan 28 07:06 ET
BioVie Partners With New to The Street for Media Campaign
TipRanksJan 13 09:35 ET
BioVie Files to Sell 7.71M Shares of Common Stock for Holders
TipRanksNov 21, 2024 17:35 ET
BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference
GlobeNewswireNov 20, 2024 08:00 ET

Comments

Jaguar8

Nov 20, 2024 07:07

NEWS

$BioVie (BIVI.US)$
BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference
BioVie (NASDAQ: BIVI) announced the acceptance of an abstract detailing their planned Phase 2 trial of bezisterim for Long COVID treatment at the Demystifying Long COVID International Conference in Barcelona. The study, fully funded by the U.S. Department of Defense, will be a double-blind, randomized, placebo-controlled tri...